Radiosensitization strategy based on DNA-PK inhibition in head and neck cancer: Emphasis on human papilloma virus (HPV)

被引:0
|
作者
Roth, Selina Moara [1 ,2 ]
Aebersold, Daniel Matthias [1 ,2 ]
Zimmer, Yitzhak [1 ,2 ]
Medova, Michaela [1 ,2 ]
机构
[1] Bern Univ Hosp, Inselspital, Radiat Oncol, Dept BioMed Res, Bern, Switzerland
[2] Univ Bern, Bern, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:591 / 591
页数:1
相关论文
共 50 条
  • [21] Erratum: The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer
    C B Lajer
    E Garnæs
    L Friis-Hansen
    B Norrild
    M H Therkildsen
    M Glud
    M Rossing
    H Lajer
    D Svane
    L Skotte
    L Specht
    C Buchwald
    F C Nielsen
    British Journal of Cancer, 2017, 117 : e2 - e2
  • [22] Growth inhibition and radiosensitization of human papillomavirus (HPV) positive head and neck cancer (HNC) by epidermal growth factor receptor inhibition is mediated by apoptosis
    Kimple, Randall J.
    Smith, Molly A.
    Blitzer, Grace C.
    Huang, Hao-Shun
    Torres, Alexandra D.
    FASEB JOURNAL, 2013, 27
  • [23] US Medical Trainees' Knowledge of Human Papilloma Virus and Head and Neck Cancer
    Laitman, Benjamin M.
    Ronner, Lukas
    Oliver, Kristin
    Genden, Eric
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2020, 162 (01) : 56 - 59
  • [24] HEAD AND NECK CANCER AND THE HUMAN PAPILLOMA VIRUS: EXPLORING DISTRESS AND QUALITY OF LIFE
    Thilges, Sarah
    Hicks, Elliott
    Mumby, Patricia
    Czerlanis, Cheryl
    Clark, Joseph
    Emami, Bahman
    Borrowdale, Richard
    Morano, Pamela
    ANNALS OF BEHAVIORAL MEDICINE, 2014, 47 : S250 - S250
  • [25] Radiosensitization of head and neck squamous cell carcinoma lines by DNA-PK inhibitors is more effective than PARP-1 inhibition and is enhanced by SLFN11 and hypoxia
    Lee, Tet Woo
    Wong, Way Wua
    Dickson, Benjamin D.
    Lipert, Barbara
    Cheng, Gary J.
    Hunter, Francis W.
    Hay, Michael P.
    Wilson, William R.
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2019, 95 (12) : 1597 - 1612
  • [26] Patient reported outcomes (PROs) in patients with human papilloma virus (HPV) positive versus negative head and neck cancer (HNC).
    Bauman, Jessica Ruth
    El-Jawahri, Areej
    Quinn, Karen
    Arcikowski, Lisa
    Chan, Gina
    Viscosi, Elene
    Doherty, Carol
    Clark, John Ross
    Wirth, Lori J.
    Temel, Jennifer S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (26)
  • [27] Human papilloma virus (HPV) type 16 and 18 detected in head and neck aquamous cell carcinoma
    Mineta, H
    Ogino, T
    Amano, HM
    Ohkawa, Y
    Araki, K
    Takebayashi, S
    Miura, K
    ANTICANCER RESEARCH, 1998, 18 (6B) : 4765 - 4768
  • [28] Targeting DNA-PK along with irradiation in head and neck cancer preclinical models suggests an HPV/p53 status-related pattern of response
    Roth, S. M.
    Aebersold, D. M.
    Medova, M.
    Zmmer, Y.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E27 - E27
  • [29] Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy
    Harima, Y
    Sawada, S
    Nagata, K
    Sougawa, M
    Ohnishi, T
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (05): : 1345 - 1351
  • [30] Human Papilloma Virus vaccine and prevention of head and neck cancer, what is the current evidence?
    Diana, Giovanni
    Corica, Clementina
    ORAL ONCOLOGY, 2021, 115